We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Drug Metabolite Safety Testing Focus of FDA Guidance
Drug Metabolite Safety Testing Focus of FDA Guidance
June 10, 2005
Drugmakers should try to identify differences in drug metabolism between animals used in nonclinical safety assessments and humans as early as possible during the drug development process to ensure timely assessment of potential safety issues, according to a FDA draft guidance.